Publications

Hogan Lovells Publications

Regulatory Insights for Life Sciences and Health Care Investments: Digital Health

Investing in the life sciences industry without an understanding of the key regulatory factors that could determine a product’s success or failure could cost you millions of dollars.

Hogan Lovells Publications

FDA proposes new regulations to govern De Novo requests – will the process live up to its promise?

Last week the Food and Drug Administration (FDA) issued a proposed set of new regulations to further define and update the De Novo review process. Although De Novo review has been available ...

Hogan Lovells Publications

Regulatory Insights for Life Sciences and Health Care Investments: Medical Device and Technology

Investing in the life sciences industry without an understanding of the key regulatory factors that could determine a product’s success or failure could cost you millions of dollars.

Hogan Lovells Publications

The Netherlands Commercial Court has arrived

On 11 December 2018, the Dutch Senate approved draft legislation introducing the Netherlands Commercial Court (NCC). The aim of the legislation is to introduce a flexible, efficient and...

Hogan Lovells Publications

Welcome to the real world: FDA issues long-awaited framework for evaluating the potential use of real-world evidence to support regulatory decisions for drugs and biologics

On December 6, the Food and Drug Administration (FDA) published a framework for its Real-World Evidence (RWE) Program to strategically leverage information gathered from real-world...

Hogan Lovells Publications

Going global: Data class actions make their way to the EU

Class actions have become an increasingly common means to seek redress in data privacy cases. With data breaches and data privacy claims on the rise, we asked our lawyers in France and the...

Hogan Lovells Publications

Employment news

Weekly newsletter on employment matters.

;
Loading data